Related Experiment Video
Updated: Jan 23, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Reprogramming Cells to Make Insulin
Wendy M McKimpson1, Domenico Accili1
1Department of Medicine (Endocrinology), Columbia University, New York, New York.
Abstract:
Type 1 diabetes is a disease characterized by the destruction of insulin-secreting β-cells in the pancreas. Individuals are treated for this disease with lifelong insulin replacement. However, one attractive treatment possibility is to reprogram an individual's endogenous cells to acquire the ability to secrete insulin, essentially replacing destroyed β-cells. Herein, we review the literature on the topic of reprogramming endodermal cells to produce insulin.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Insulin Secretory Vesicles
Insulin: The Receptor and Signaling Pathways
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Introduction to Nuclear Reprogramming
Methods of Nuclear Reprogramming

